Journal
JOURNAL OF CHEMICAL INFORMATION AND MODELING
Volume 60, Issue 12, Pages 5682-5698Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jcim.0c00599
Keywords
-
Categories
Funding
- NSF [DMS-1721024, DMS-1761320, IIS1900473]
- NIH [GM126189]
- Michigan Economic Development Corporation
- Pfizer
- Bristol-Myers Squibb
Ask authors/readers for more resources
Current drug discovery is expensive and time-consuming. It remains a challenging task to create a wide variety of novel compounds that not only have desirable pharmacological properties but also are cheaply available to low-income people. In this work, we develop a generative network complex (GNC) to generate new drug-like molecules based on the multiproperty optimization via the gradient descent in the latent space of an autoencoder. In our GNC, both multiple chemical properties and similarity scores are optimized to generate drug-like molecules with desired chemical properties. To further validate the reliability of the predictions, these molecules are reevaluated and screened by independent 2D fingerprint-based predictors to come up with a few hundreds of new drug candidates. As a demonstration, we apply our GNC to generate a large number of new BACE1 inhibitors, as well as thousands of novel alternative drug candidates for eight existing market drugs, including Ceritinib, Ribociclib, Acalabrutinib, Idelalisib, Dabrafenib, Macimorelin, Enzalutamide, and Panobinostat.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available